Ftse Mib
33.308,77
-1,09%
DAX
18.163,52
-0,41%
S&P 500
5.464,62
-0,16%
NASDAQ
17.689,36
-0,18%
Bitcoin
64.271,56
0,29%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cabaletta Bio Inc (CABA) Cabaletta Bio Inc (CABA) Notizie

CABA

Cabaletta Bio (CABA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CABA
DataOraFonteTitoloSimboloCompagnia
14/06/202412:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CABACabaletta Bio Inc
14/06/202408:00GlobeNewswire Inc.Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201NASDAQ:CABACabaletta Bio Inc
05/06/202401:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
29/05/202414:00GlobeNewswire Inc.Cabaletta Bio to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:CABACabaletta Bio Inc
15/05/202413:53Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CABACabaletta Bio Inc
15/05/202413:00GlobeNewswire Inc.Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:CABACabaletta Bio Inc
13/05/202414:00GlobeNewswire Inc.Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQNASDAQ:CABACabaletta Bio Inc
21/03/202412:00GlobeNewswire Inc.Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:CABACabaletta Bio Inc
20/03/202412:00GlobeNewswire Inc.Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Systemic SclerosisNASDAQ:CABACabaletta Bio Inc
27/02/202414:00GlobeNewswire Inc.Cabaletta Bio to Participate in Upcoming Investor Conferences in MarchNASDAQ:CABACabaletta Bio Inc
14/02/202415:20Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CABACabaletta Bio Inc
01/02/202422:30GlobeNewswire Inc.Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of MyositisNASDAQ:CABACabaletta Bio Inc
31/01/202414:00GlobeNewswire Inc.Cabaletta Bio to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:CABACabaletta Bio Inc
08/01/202413:00GlobeNewswire Inc.Cabaletta Bio Receives Additional FDA Fast Track Designations for CABA-201 in Dermatomyositis and Systemic SclerosisNASDAQ:CABACabaletta Bio Inc
02/01/202414:00GlobeNewswire Inc.Cabaletta Bio to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:CABACabaletta Bio Inc
29/11/202312:18IH Market NewsAmazon Unveils Innovative Services, Okta Discloses Data Breach, Textron Plans 2% Global Workforce Reduction, and MoreNASDAQ:CABACabaletta Bio Inc
28/11/202322:30GlobeNewswire Inc.Cabaletta Bio to Participate in the 6th Annual Evercore ISI HealthCONx ConferenceNASDAQ:CABACabaletta Bio Inc
28/11/202320:59Dow Jones NewsCabaletta Bio Down as FDA Looks Into Issues With Several Companies' Approved CAR T DrugsNASDAQ:CABACabaletta Bio Inc
20/11/202322:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CABACabaletta Bio Inc
09/11/202313:00GlobeNewswire Inc.Cabaletta Bio Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:CABACabaletta Bio Inc
06/11/202314:15Business WireCellares and Cabaletta Bio Partner to Evaluate Automated Manufacturing for CABA-201, Cabaletta’s CD19-CAR T Cell Therapy on Cellares’ Cell Shuttle PlatformNASDAQ:CABACabaletta Bio Inc
06/11/202313:55Dow Jones NewsCabaletta Bio Gets FDA OK to Study CABA-201 in Generalized Myasthenia GravisNASDAQ:CABACabaletta Bio Inc
06/11/202313:00GlobeNewswire Inc.Cabaletta Bio Receives FDA Clearance of CABA-201 IND Application for Treatment of Generalized Myasthenia GravisNASDAQ:CABACabaletta Bio Inc
30/10/202313:00GlobeNewswire Inc.Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in NovemberNASDAQ:CABACabaletta Bio Inc
02/10/202313:00GlobeNewswire Inc.Cabaletta Bio Receives FDA Clearance of IND Application for Treatment of Systemic Sclerosis with CABA-201NASDAQ:CABACabaletta Bio Inc
19/09/202314:00GlobeNewswire Inc.Cabaletta Bio to Participate in Upcoming Investor Conferences in SeptemberNASDAQ:CABACabaletta Bio Inc
30/08/202314:00GlobeNewswire Inc.Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in SeptemberNASDAQ:CABACabaletta Bio Inc
22/08/202314:00GlobeNewswire Inc.Cabaletta Bio and WuXi Advanced Therapies Announce Expansion of GMP Manufacturing Agreement to Include CABA-201NASDAQ:CABACabaletta Bio Inc
10/08/202313:57Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CABACabaletta Bio Inc
10/08/202313:00GlobeNewswire Inc.Cabaletta Bio Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:CABACabaletta Bio Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CABA

La tua Cronologia

NEO
APLY
Apple AAPL Yield Shares ...
CXIO
LEVERUSD
LeverFi
USOTC
SLTTF
Slate Office REIT (PK)
COIN
FOURUSD
The 4th Pillar Token
LSE
BM22
Citi Fun 27
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network